CAPPED-BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000LB34JP8

Delayed Deutsche Boerse AG 11:15:08 2024-06-26 EDT
34.89 EUR +0.06% Intraday chart for CAPPED-BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+0.23%
1 month+0.43%
Date Price Change
24-06-26 34.89 +0.06%
24-06-25 34.87 -0.03%
24-06-24 34.88 +0.23%
24-06-21 34.8 -0.09%
24-06-20 34.83 +0.09%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 11:15 am

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer LBBW
WKN LB34JP
ISINDE000LB34JP8
Date issued 2022-11-07
Strike 35.5
Maturity 2024-11-15 (142 Days)
Parity 1 : 1
Emission price 27.41
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 34.89
Lowest since issue 27.48
Spread 0.35
Spread %0.99%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.68 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.03%
Consensus